UW Medicine Spring in Seattle XIX Clinical Cardiology Pearls for Primary Care 2020

Monday, April 27, 2020, 8:00 AM – Tuesday, April 28, 2020, 1:00 PM

Clinical Cardiology Pearls for Primary Care This course is tailored for a primary care audience and is intended to provide practical, up-to-date information on commonly encountered cardiovascular diseases. World-class faculty from the University of Washington School of Medicine will teach participants using case-based lectures and an audience response system to encourage interactive dialogue.

Recent guidelines for hypertension, cholesterol management, and diabetes will be reviewed. Everyday primary care topics including diagnosis and treatment of coronary artery disease, congestive heart failure, valvular heart disease and supraventricular arrhythmias, including atrial fibrillation, will be covered. Practical issues regarding use of new anticoagulants will be discussed. Appropriateness of cardiac testing will be discussed during lectures on the cardiovascular physical exam and the evaluation of chest pain with stress testing.

1. Treat and manage high blood pressure based on updated clinical guidelines.
2. Apply new cholesterol guidelines and novel cholesterol treatments to the management of patients with cardiac risk factors and atherosclerotic vascular disease.
3. Order the appropriate stress test for patients based on current guidelines.
4. Evaluate and manage patients with valvular heart disease; identify which heart murmur patients should be referred for an echocardiogram and when patients should be referred for valve repair or replacement.
5. Manage patients with chronic stable coronary artery disease.
6. Diagnose and treat patients with palpitations, and understand the appropriate use of heart rhythm monitors and when to refer patients to cardiology.
7. Evaluate and treat atrial fibrillation and learn how to use direct oral anticoagulants to reduce stroke risk from atrial fibrillation.
8. Evaluate and treat patients with congestive heart failure.
9. Evaluate patients with syncope with appropriate use of cardiovascular testing when indicated.
10. Utilize novel diabetes drugs that have proven benefit in reducing cardiovascular events.